sb 203580 has been researched along with carbobenzoxy-leucyl-leucyl-norvalinal in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (carbobenzoxy-leucyl-leucyl-norvalinal) | Trials (carbobenzoxy-leucyl-leucyl-norvalinal) | Recent Studies (post-2010) (carbobenzoxy-leucyl-leucyl-norvalinal) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 84 | 0 | 16 |
| Protein | Taxonomy | sb 203580 (IC50) | carbobenzoxy-leucyl-leucyl-norvalinal (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 3.14 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.1401 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, I; Hatakeyama, M; Imaizumi, T; Matsumiya, T; Munakata, H; Satoh, K; Shibata, T; Tamo, W; Yoshida, H | 1 |
1 other study(ies) available for sb 203580 and carbobenzoxy-leucyl-leucyl-norvalinal
| Article | Year |
|---|---|
Effect of MG132, a proteasome inhibitor, on the expression of growth related oncogene protein-alpha in human umbilical vein endothelial cells.
Topics: Acetylcysteine; Anthracenes; Cells, Cultured; Chemokine CXCL1; Chemokines, CXC; Cysteine Proteinase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation; Humans; I-kappa B Proteins; Imidazoles; Intercellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Leupeptins; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Umbilical Veins | 2003 |